Published in Int J Stroke on May 01, 2008
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Endovascular treatment for acute ischemic stroke. N Engl J Med (2013) 8.45
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ (2016) 2.17
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke (2011) 1.92
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Equipoise among recanalization strategies. Neurology (2010) 1.77
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology (2014) 1.46
Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of Interventional Management of Stroke (IMS) III Trial. Stroke (2015) 1.43
Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke (2013) 1.24
The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials (2013) 1.06
Initial experience with a self-expanding retrievable stent for recanalization of large vessel occlusions in acute ischemic stroke. Neuroradiology (2011) 1.05
Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab (2011) 0.99
Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag (2009) 0.98
Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis. J Neurosurg (2011) 0.97
Predictive factors of outcome and hemorrhage after acute ischemic stroke treated by mechanical thrombectomy with a stent-retriever. Neuroradiology (2013) 0.97
Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation (2014) 0.96
Machine learning for outcome prediction of acute ischemic stroke post intra-arterial therapy. PLoS One (2014) 0.94
Thrombolytic therapy for acute ischemic stroke beyond three hours. J Emerg Med (2010) 0.90
2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg (2013) 0.90
Revascularization grading in endovascular acute ischemic stroke therapy. Neurology (2012) 0.90
Stroke center certification: where are we in 2010? J Neurointerv Surg (2010) 0.89
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke (2015) 0.88
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke (2014) 0.86
A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials (2011) 0.86
Comparison of time to treatment between intravenous and endovascular thrombolytic treatments for acute ischemic stroke. J Vasc Interv Neurol (2011) 0.85
Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology. J Vasc Interv Neurol (2014) 0.84
Intra-arterial treatment methods in acute stroke therapy. Front Neurol (2011) 0.84
Admission clinical characteristics and early clinical outcomes among acute ischemic stroke patients. J Biomed Res (2012) 0.83
Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke (2014) 0.83
Reperfusion therapies of acute ischemic stroke: potentials and failures. Front Neurol (2014) 0.81
Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs (2013) 0.80
How well do blood flow imaging and collaterals on angiography predict brain at risk? Neurology (2012) 0.80
Social factors influencing hospital arrival time in acute ischemic stroke patients. Neuroradiology (2011) 0.79
Recanalization therapy for acute ischemic stroke, part 2: mechanical intra-arterial technologies. Neurosurg Rev (2010) 0.78
Clinical trial design for endovascular ischemic stroke intervention. Neurology (2012) 0.78
Mechanical Recanalization following i.v. Thrombolysis: A Retrospective Analysis regarding Secondary Hemorrhagic Infarctions and Parenchymal Hematomas. Radiol Res Pract (2015) 0.78
Endovascular thrombectomy following acute ischemic stroke: a single-center case series and critical review of the literature. Brain Sci (2013) 0.78
Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke. Front Neurol (2011) 0.77
Poor clinical outcome despite successful arterial recanalization. What went wrong? How can we do better? Neuroradiology (2010) 0.77
Mild acute ischaemic stroke--the case for thrombolytic therapy. Nat Rev Neurol (2013) 0.77
Developments on the horizon in the treatment of neurovascular problems. Surg Neurol Int (2013) 0.76
Recanalization therapy for acute ischemic stroke, part 1: surgical embolectomy and chemical thrombolysis. Neurosurg Rev (2010) 0.76
Stent Retriever-Based Thrombectomy in Octogenarians. Interv Neurol (2016) 0.75
Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial. Interv Neurol (2016) 0.75
Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal. Front Neurol (2011) 0.75
Modern interventional management of stroke. Methodist Debakey Cardiovasc J (2014) 0.75
Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients. Sci Rep (2017) 0.75
Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale. Interv Neurol (2016) 0.75
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA (1999) 12.75
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke (2004) 4.67
Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology (1992) 3.40
Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol (1993) 2.91
Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke (1997) 2.83
Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol (2006) 2.39
Intracranial hemorrhage associated with revascularization therapies. Stroke (2007) 2.08
Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 1.89
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke (1992) 1.64
Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology (2005) 1.27
Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke (2000) 1.22
Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke. Stroke (2002) 1.10
Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery (2002) 1.00
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA (2004) 6.98
Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med (2004) 5.32
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 4.59
Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke (2005) 4.07
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol (2007) 3.72
Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke (2005) 3.67
Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology (2012) 3.62
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke (2002) 3.43
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke (2008) 3.40
Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke (2007) 3.34
Very early administration of progesterone for acute traumatic brain injury. N Engl J Med (2014) 3.20
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology (2012) 3.02
Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke (2004) 2.97
Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke (2007) 2.93
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke (2010) 2.79
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke (2006) 2.77
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation (2002) 2.71
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Trends in community knowledge of the warning signs and risk factors for stroke. JAMA (2003) 2.40
Vein of Galen aneurysmal malformation: diagnosis and treatment of 13 children with extended clinical follow-up. AJNR Am J Neuroradiol (2002) 2.38
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis (2007) 2.36
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2012) 2.34
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke (2005) 2.26
Individual patient data subgroup meta-analysis of surgery for spontaneous supratentorial intracerebral hemorrhage. Stroke (2012) 2.26
Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke (2003) 2.22
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke (2004) 2.22
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J (2008) 2.09
Intracranial hemorrhage associated with revascularization therapies. Stroke (2007) 2.08
Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke (2005) 2.08
Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke (2003) 2.05
Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke (2006) 2.04
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. J Neurosurg (2014) 2.01
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01
Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke (2002) 1.97
Escalating levels of access to in-hospital care and stroke mortality. Stroke (2008) 1.97
Intravenous thrombolysis for acute ischaemic stroke in young adult patients. Can J Neurol Sci (2009) 1.95
CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke (2012) 1.92
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke (2011) 1.92